approxim
million
world
popul
year
age
number
predict
increas
reach
billion
equival
world
total
popul
et
al
rapid
increas
age
popul
due
lower
fertil
rate
advanc
health
care
lead
longer
life
expect
rise
proport
older
individu
creat
uniqu
challeng
health
care
system
sinc
despit
decreas
death
rate
incid
multimorbid
multipl
concurr
health
condit
depress
arthriti
hepat
neuropathi
hypertens
increas
age
et
al
moreov
although
lead
contributor
morbid
mortal
noncommunic
diseas
cardiovascular
diseas
lung
diseas
cancer
older
adult
still
account
larger
share
infect
alter
immun
respons
elderli
respons
chronic
inflamm
increas
suscept
infect
ponnappan
ponnappan
furthermor
onethird
individu
live
hiv
north
america
western
europ
older
mahi
et
al
therefor
number
elderli
individu
rapidli
increas
studi
age
agerel
diseas
take
new
urgenc
biomed
research
area
requir
use
anim
model
faith
recapitul
differ
physiolog
aspect
age
human
chapter
focu
util
nonhuman
primat
model
studi
effect
age
immun
fit
understand
mechan
cellular
senesc
heavili
depend
use
appropri
anim
model
elucid
underli
causal
mechan
date
understand
biolog
chang
occur
age
come
studi
util
rodent
model
advantag
rodent
model
includ
extens
set
reagent
presenc
genet
modifi
strain
short
lifespan
allow
longev
studi
short
durat
howev
rodent
separ
human
million
year
ago
make
less
ideal
translat
research
rodent
model
also
present
numer
challeng
investig
immun
system
exampl
peripher
immun
system
rodent
continu
develop
birth
contrast
human
born
fulli
popul
lymphoid
immun
system
includ
variou
b
cell
subset
special
lymphoid
tissu
well
abil
respond
wide
rang
antigen
hein
griebel
contrast
nonhuman
primat
nhp
share
signific
genet
physiolog
homolog
well
behavior
characterist
human
outbr
natur
nhp
enabl
rigor
valid
research
find
goe
beyond
proof
principl
provid
rodent
model
furthermor
comorbid
age
nhp
close
mirror
seen
human
includ
develop
agerel
diseas
perturb
sleepwak
cycl
cognit
declin
cataract
macular
degener
loss
motor
skill
impair
memori
acquisit
social
motiv
shift
diabet
hypertens
osteoporosi
pancreat
neurolog
amyloid
deposit
atherosclerosi
nadon
shive
clarkson
almel
et
al
phillip
et
al
diseas
appear
modifi
strain
variou
form
genet
manipul
alway
recapitul
clinic
pictur
contrast
appear
diseas
nhp
especi
atherosclerosi
increas
age
consumpt
western
diet
similar
describ
human
nadon
shive
clarkson
moreov
describ
human
femal
male
rhesu
macaqu
undergo
menopaus
andropaus
respect
weinbauer
et
al
urbanski
sorwel
nhp
also
suscept
human
pathogen
close
relat
simian
counterpart
kennedi
et
al
moreov
nhp
consist
predict
drug
pharmacokinet
human
rodent
model
ward
et
al
final
nhp
includ
sever
longliv
speci
therefor
nhp
offer
robust
translat
model
studi
variou
aspect
human
age
allow
us
conduct
mechanist
studi
control
condit
outbr
speci
close
mimic
human
biolog
close
evolutionari
relationship
human
ensur
high
fidel
model
uniqu
predict
valu
human
diseas
nhp
classifi
two
broad
group
old
world
monkey
eg
macaqu
baboon
nativ
asia
africa
new
world
monkey
eg
marmoset
squirrel
spider
monkey
nativ
south
central
america
roger
gibb
old
world
monkey
speci
closest
evolutionari
relationship
human
brosnan
et
al
new
world
monkey
phylogenet
distant
homo
sapien
estim
new
world
monkey
diverg
million
year
ago
wherea
old
world
monkey
diverg
million
year
ago
kennedi
et
al
inde
studi
util
coordin
game
better
understand
cognit
mechan
found
old
world
monkey
act
similar
human
new
world
monkey
brosnan
et
al
moreov
contrast
old
world
monkey
reagent
valid
crossreact
new
world
monkey
cell
nonetheless
group
present
advantag
smaller
size
eas
handl
reduc
risk
zoonot
diseas
transmiss
salmon
consequ
use
marmoset
becom
increasingli
common
salmon
ross
et
al
recent
studi
highlight
util
model
number
agerel
diseas
includ
parkinson
diseas
diabet
cardiovascular
diseas
cancer
renal
diseas
salmon
howev
macaqu
remain
prefer
nhp
resourc
biomed
research
two
commonli
use
nhp
model
biomed
research
rhesu
macaqu
macaca
mulatta
cynomolgu
longtail
macaqu
macaca
fasciculari
chimpanze
bonobo
evolutionarili
nearest
live
rel
human
would
faith
repres
human
age
howev
practic
ethic
consider
statu
endang
speci
long
life
span
year
captiv
make
less
appeal
age
research
nih
end
support
chimpanze
research
endang
speci
protect
act
rhesu
macaqu
macaca
mulatta
genom
share
homolog
human
roger
gibb
compar
gccontent
vs
rhesu
macaqu
genom
et
al
major
proteincod
gene
homolog
among
human
old
world
monkey
sequenc
date
howev
gene
famili
expand
contract
individu
lineag
one
studi
estim
gene
new
duplic
rhesu
genom
compar
human
hla
gene
cluster
exampl
critic
respons
pathogen
well
immunolog
process
expand
macaqu
rel
human
roger
gibb
densiti
snp
also
significantli
higher
rhesu
macaqu
compar
human
includ
singleton
million
singl
nucleotid
variant
found
rhesu
macaqu
genom
compar
million
snp
includ
singleton
per
human
individu
accord
genom
project
roger
gibb
macaqu
also
longliv
suggest
similar
pattern
age
may
evolv
close
relat
primat
speci
anim
categor
young
adult
year
old
middleag
year
old
old
year
old
senil
year
old
oldest
anim
live
year
tigg
et
al
earli
observ
rhesu
macaqu
coloni
indic
median
surviv
time
year
male
femal
respect
tigg
et
al
howev
later
studi
observ
survivorship
year
male
year
femal
dyke
et
al
confirm
recent
longterm
studi
report
averag
lifespan
year
maximum
lifespan
year
rhesu
macaqu
bodkin
et
al
oldest
human
surviv
year
rhesu
macaqu
maximum
lifespan
approxim
onethird
human
experiment
anim
model
nhp
present
sever
advantag
challeng
major
strength
includ
genet
physiolog
behavior
similar
human
well
suscept
human
diseas
pathogen
discuss
furthermor
nhp
maintain
care
control
environ
eg
photoperiod
temperatur
diet
medic
reduc
confound
factor
selfselect
bia
often
unavoid
human
clinic
trial
vandeberg
williamsblangero
use
nhp
also
advantag
similar
techniqu
eg
activ
record
mri
ct
scan
pet
scan
telemetri
deploy
anoth
advantag
nhp
larger
size
allow
longitudin
crosssect
assess
multipl
organ
system
use
critic
surgic
procedur
bronchoalveolar
lavag
laparoscop
surgeri
punch
biopsi
tardif
et
al
advantag
provid
possibl
test
new
drug
vaccin
intervent
truli
translat
model
howev
longer
lifespan
nhp
compar
laboratori
anim
also
challeng
use
nhp
biogerontolog
research
lifespan
consider
shorter
human
still
prohibit
longitudin
studi
moreov
limit
avail
age
nhp
high
cost
associ
nhp
research
special
hous
requir
prohibit
research
final
everincreas
level
regul
concern
use
nhp
research
major
burden
overcom
limit
nation
institut
health
nih
develop
special
resourc
encourag
promot
use
nhp
model
age
research
nih
support
seven
nation
primat
research
center
nprc
provid
effect
infrastructur
suppli
hous
nhp
benefit
research
human
diseas
macaqu
repres
major
nhp
hous
nprc
old
world
speci
african
green
sooti
mangabey
baboon
well
sever
new
world
speci
marmoset
also
hous
nprc
nation
institut
age
nia
made
signific
invest
resourc
facilit
use
nhp
age
research
includ
mainten
sever
coloni
age
macaqu
primat
age
studi
well
nhp
tissu
bank
archiv
frozen
fix
tissu
collect
age
rhesu
macaqu
variou
coloni
nadon
addit
primat
age
databas
pad
develop
via
collabor
nih
intramur
extramur
program
nadon
databas
bring
togeth
blood
chemistri
paramet
bodi
weight
collect
thousand
monkey
nprc
data
mostli
gener
healthi
anim
limit
util
find
obtain
studi
anim
nia
also
establish
cell
bank
contain
cell
line
variou
nhp
speci
well
dna
extract
young
age
individu
differ
nhp
speci
resourc
avail
research
commun
order
promot
investig
benefit
use
age
nhp
model
immun
system
protect
bodi
elimin
microbi
threat
limit
damag
host
achiev
coordin
action
two
subsystem
innat
adapt
immun
system
major
differ
two
branch
innat
immun
broadli
recogn
antigen
use
germlineencod
receptor
wherea
adapt
immun
tailor
detect
specif
pathogen
highli
divers
set
receptor
gener
via
recombin
somat
mutat
anoth
distinguish
featur
abil
adapt
immun
system
develop
immunolog
memori
upon
reencount
antigen
result
increas
effici
respond
cell
section
chapter
summar
understand
innat
adapt
immun
system
rhesu
macaqu
review
similar
differ
human
immun
system
innat
immun
system
first
line
defens
pathogen
compos
primarili
neutrophil
monocytesmacrophag
dendrit
cell
dc
natur
killer
nk
cell
innat
cell
use
germlineencod
receptor
recogn
conserv
pathogenassoci
molecular
pattern
pamp
thu
receptor
refer
pathogen
recognit
receptor
prr
wellknown
famili
prr
tolllik
receptor
tlr
retino
acidinduc
gene
rigi
like
rna
helicas
rlh
nodlik
receptor
nlr
includ
nod
nalp
recognit
foreign
antigen
prr
initi
intracellular
signal
result
product
antimicrobi
antivir
molecul
inhibit
pathogen
replic
spread
innat
immun
branch
play
critic
role
activ
adapt
immun
respons
via
antigen
process
present
well
product
cytokin
chemokin
section
focu
monocytesmacrophag
dc
nk
cell
function
rhesu
macaqu
sinc
limit
inform
avail
nhp
neutrophil
basophil
eosinophil
discuss
monocyt
dc
scaveng
cell
ingest
destroy
infecti
agent
also
serv
profession
antigenpres
cell
apc
respons
process
present
foreign
antigen
peptid
cell
therebi
link
innat
adapt
immun
human
three
subset
monocyt
identifi
differenti
express
wong
et
al
classic
monocyt
mainli
function
phagocytosi
identifi
constitut
major
monocyt
rest
physiolog
condit
intermedi
monocyt
express
high
level
higher
capac
releas
respons
lp
compar
classic
monocyt
wong
et
al
nonclass
monocyt
identifi
major
produc
addit
nitric
oxid
wong
et
al
rhesu
macaqu
exhibit
distribut
function
three
subset
monocyt
also
differenti
express
fig
sugimoto
et
al
addit
viral
infect
simian
varicella
viru
svv
simian
immunodefici
viru
siv
increas
frequenc
intermedi
nonclass
monocyt
kim
et
al
haberthur
et
al
moreov
follow
siv
infect
rhesu
macaqu
classic
monocyt
express
highest
level
follow
intermedi
monocyt
wherea
nonclass
monocyt
express
kim
et
al
human
dc
identifi
base
express
class
ii
major
histocompat
complex
mhcii
absenc
b
macrophag
marker
hladr
subdivid
either
myeloid
dc
mdc
plasmacytoid
dc
pdc
okeeff
et
al
myeloid
dc
process
present
antigen
cell
produc
produc
limit
amount
antivir
cytokin
okeeff
et
al
contrast
pdc
abl
produc
larg
amount
respons
viral
infect
okeeff
et
al
myeloid
dc
pdc
identifi
rhesu
macaqu
use
surfac
marker
describ
human
autissi
et
al
function
similar
fig
viral
infect
result
mobil
recruit
pdc
gener
robust
type
ifn
respons
haberthur
et
al
chung
et
al
teleshova
et
al
harri
et
al
also
use
marker
cynomolgu
macaqu
mdc
coexpress
therefor
express
may
requir
avoid
underestim
mdc
number
macaqu
autissi
et
al
malleret
et
al
less
differenti
dc
lddc
identifi
pregnant
women
cord
blood
patient
rheumatoid
arthriti
aldebert
et
al
dombrecht
et
al
subtyp
also
describ
rhesu
macaqu
frequenc
alter
follow
radiat
immunosuppress
treatment
meyer
et
al
importantli
lddc
describ
mice
express
tlr
among
differ
dc
subset
ident
human
macaqu
differ
murin
dc
ketloy
et
al
rhesu
macaqu
mdc
express
upregul
costimulatori
molecul
upon
tlr
stimul
ketloy
et
al
similarli
pdc
express
respond
viral
infect
initi
product
addit
upregul
chung
et
al
teleshova
et
al
ketloy
et
al
furthermor
pdc
human
rhesu
macaqu
constitut
express
high
level
critic
induc
transcript
chung
et
al
contrast
function
mice
plasma
cell
naiv
b
cell
less
differenti
igd
igd
igd
igd
fig
nonhuman
primat
nhp
human
immun
cell
identifi
use
similar
marker
cell
innat
adapt
branch
identifi
use
similar
cell
surfac
marker
human
nhp
contrast
compar
subset
identifi
use
differ
set
marker
rodent
broadli
express
sever
cell
type
includ
dc
b
cell
macrophag
monocyt
edward
et
al
differ
provid
justif
need
use
nhp
evalu
adjuv
vivo
final
compar
method
develop
mobil
circul
dc
vivo
use
either
hematopoiet
growth
factor
ligand
teleshova
et
al
progp
chimer
molecul
gcsf
mobil
mdc
pdc
nhp
koopman
et
al
nk
cell
nk
cell
recogn
miss
self
alter
self
elimin
tumor
viru
infect
cell
nk
cell
also
bridg
innat
adapt
immun
secret
specif
cytokin
chemokin
turn
modul
kinet
magnitud
cell
respons
human
nk
cell
identifi
subdivid
base
express
lanier
nk
cell
make
major
blood
spleen
nk
cell
highli
cytotox
secret
moder
amount
inflammatori
cytokin
nk
cell
hand
exhibit
poor
cytotox
secret
larg
amount
inflammatori
cytokin
lanier
character
nk
cell
differ
slightli
nhp
human
fig
first
marker
monocyt
nk
cell
rhesu
macaqu
carter
et
al
second
unlik
human
nk
cell
macaqu
nk
cell
express
high
level
webster
johnson
therefor
nk
cell
nhp
identifi
still
divid
cytolyt
popul
minor
cytokineproduc
popul
describ
human
balanc
signal
gener
either
inhibit
activ
receptor
determin
nkmediat
activ
lanier
inhibitori
nk
receptor
divid
either
killer
immunoglobulinlik
receptor
kir
ctype
lectin
receptor
interact
specif
allel
form
mhci
molecul
inhibit
nk
cell
kill
lanier
howev
signal
via
inhibitori
receptor
absent
nk
cellmedi
lytic
activ
trigger
via
activ
receptor
cell
surfac
ligand
pathogeninfect
tumor
cell
lanier
inhibitori
nk
receptor
well
activ
receptor
rhesu
macaqu
human
exhibit
high
degre
sequenc
mavilio
et
al
function
homolog
mavilio
et
al
clinic
studi
suggest
nk
cell
impact
progress
sever
sever
viral
infect
notabl
human
immunodefici
viru
hiv
alter
altfeld
import
nk
cell
function
host
respons
hiv
investig
use
siv
model
choi
et
al
rhesu
macaqu
deplet
nk
cell
siv
infect
use
human
monoclon
antibodi
experienc
higher
peak
viral
load
differ
detect
chronic
phase
diseas
furthermor
macaqu
alreadi
infect
siv
administr
human
monoclon
antibodi
alter
set
viral
load
choi
et
al
suggest
nk
cell
modul
sever
sivhiv
infect
studi
repres
exampl
role
specif
immun
cell
interrog
robust
translat
model
human
diseas
advanc
understand
mechan
microbi
pathogenesi
adapt
immun
respons
mediat
b
cell
express
highli
divers
set
receptor
gener
recombin
somat
mutat
adapt
immun
also
develop
immunolog
memori
result
enhanc
effector
respons
upon
reexposur
antigen
cell
compart
cell
respons
cellmedi
respons
pathogen
stem
progenitor
cell
thymu
cell
util
cell
receptor
tcr
recogn
antigen
form
small
peptid
bound
either
mhci
mhcii
molecul
cell
also
known
helper
cell
recogn
peptid
bound
mhcii
secret
cytokin
import
differenti
b
cell
antibodyproduc
plasma
cell
develop
cytotox
cell
cell
recogn
peptid
bound
mhci
upon
recognit
abl
kill
cell
contain
intracellular
pathogen
tumor
cell
highli
divers
tcr
repertoir
gener
recombin
differ
tcr
variabl
v
divers
join
j
constant
c
segment
tcr
chain
random
nucleotid
addit
delet
junction
segment
pair
differ
chain
possibl
tcr
combin
human
cell
repertoir
arstila
et
al
analysi
rhesu
macaqu
tcr
divers
reveal
tcr
gene
share
signific
homolog
human
homologu
thiel
et
al
greenaway
et
al
specif
sequenc
rhesu
macaqu
tcra
chain
clone
reveal
tcrav
tcraj
region
correspond
close
human
counterpart
variat
occur
end
thiel
et
al
furthermor
studi
sequenc
cdna
gene
rhesu
macaqu
show
extens
conserv
human
sequenc
comparison
rhesu
human
trb
gene
show
similar
greenaway
et
al
specif
trbv
trbd
trbj
gene
extract
rhesu
macaqu
genom
averag
similar
correspond
human
homolog
respect
greenaway
et
al
mhc
molecul
present
divers
pool
peptid
tcr
recognit
human
mhc
class
loci
hlaa
b
c
three
mhcii
loci
hladp
dq
dr
locu
encod
multipl
allel
polymorph
alloc
peptidebind
region
hugh
yeager
genet
differ
mhc
loci
macaqu
human
although
rhesu
macaqu
three
mhcii
loci
dp
dq
dr
two
mhci
loci
b
doxiadi
et
al
furthermor
sequenc
complet
rhesu
macaqu
mhc
locu
reveal
major
expans
six
human
mhci
gene
mani
activ
mhci
gene
rhesu
moreov
high
level
genet
polymorph
found
mhc
region
high
higher
sequenc
diverg
human
dazavamenta
et
al
marker
defin
human
cell
subset
also
use
rhesu
macaqu
fig
human
nhp
cell
identifi
base
express
divid
cell
human
cell
defin
antigen
encount
memori
cell
gain
express
lose
express
mahnk
et
al
also
use
identifi
cell
rhesu
macaqu
howev
express
antigen
experienc
cell
common
macaqu
pitcher
et
al
reliabl
identifi
memori
cell
macaqu
wang
et
al
therefor
macaqu
studi
reli
express
costimulatori
molecul
fa
receptor
delin
three
major
subset
na
central
memori
cm
effector
memori
em
pitcher
et
al
precis
differenti
peripher
memori
cell
made
express
chemokin
receptor
repres
termin
differenti
em
cell
delin
cm
cell
cell
repres
transit
popul
picker
et
al
use
also
use
delin
memori
subset
human
well
mahnk
et
al
surviv
cell
depend
mhc
contact
induc
homeostat
prolifer
cell
contrast
memori
cell
requir
mhc
contact
instead
requir
surviv
surh
sprent
cell
homeostasi
nhp
similar
requir
describ
human
rodent
gene
encod
rhesu
high
genet
amino
acid
function
similar
human
rodent
homologu
ansari
et
al
furthermor
administr
recombin
rhesu
induc
prolifer
central
memori
cell
result
increas
frequenc
villing
et
al
prolifer
em
cell
picker
et
al
villing
et
al
one
differ
mous
human
critic
b
cell
surviv
mice
requir
cell
surviv
human
roifman
et
al
surh
sprent
similarli
requir
cell
surviv
rhesu
macaqu
vassena
et
al
b
cell
respons
humor
respons
pathogen
stem
progenitor
cell
bone
marrow
differenti
matur
b
cell
follow
rearrang
heavi
h
light
l
chain
make
b
cell
receptor
bcr
crowley
et
al
bcr
h
l
chain
variabl
region
highli
conserv
human
macaqu
facilit
b
cell
matur
studi
nhp
bibl
et
al
ermert
et
al
link
et
al
human
peripher
b
cell
identifi
express
distinguish
base
express
igd
b
cell
igd
memori
b
cell
igd
margin
zone
b
cell
igd
repres
transit
memori
popul
baror
et
al
doubl
neg
memori
b
cell
igd
identifi
healthi
patient
found
increas
individu
autoimmun
diseas
wei
et
al
marker
use
delin
b
cell
subset
macaqu
fig
haberthur
et
al
upon
activ
lymphoid
tissu
b
cell
undergo
prolifer
differenti
igsecret
plasma
cell
longliv
memori
b
cell
caraux
et
al
isotyp
class
switch
ie
igm
igg
iga
ige
somat
hypermut
also
occur
result
antigenexperienc
memori
b
cell
produc
high
affin
antibodi
caraux
et
al
similar
process
describ
macaqu
instanc
siv
infect
germin
center
support
antigendriven
somat
hypermut
antibodi
follow
rate
nucleotid
substitut
select
similar
describ
human
infect
hiv
margolin
et
al
kuhrt
et
al
activ
rhesu
macaqu
b
cell
result
upregul
costimulatori
molecul
observ
human
human
circul
antibodi
secret
plasma
cell
defin
caraux
et
al
rhesu
macaqu
plasma
cell
slightli
differ
phenotyp
compar
human
show
phenotyp
fig
neumann
et
al
gut
microbiom
commun
microb
coevolv
host
mutualist
relationship
protect
enter
infect
competit
resourc
stimul
develop
immun
system
mucos
barrier
kaiko
stappenbeck
microbi
cell
previous
thought
outnumb
mammalian
revis
estim
believ
closer
sender
et
al
healthi
human
microbiom
domin
bacteroidet
firmicut
bacteroid
abund
preval
bacteri
genu
gi
tract
lloydpric
et
al
one
studi
date
character
biogeographi
rhesu
intestin
mucos
lumen
microbiom
use
sampl
healthi
older
femal
year
yasuda
et
al
analysi
fecal
materi
along
pair
lumen
mucos
sampl
ten
site
distal
jejunum
reveal
macaqu
stool
microbiota
repres
composit
present
colon
lumen
mucosa
similar
composit
seen
human
rhesu
macaqu
intestin
primarili
colon
bacteroidet
firmicut
proteobacteria
phyla
contrast
human
actinobacteria
verrucomicrobia
rare
rhesu
macaqu
spirochaet
genu
helicobact
abund
second
studi
analyz
gut
microbi
commun
diet
multipl
primat
speci
live
wild
sanctuari
full
captiv
also
found
captiv
loss
dietari
fiber
nhp
associ
loss
nativ
gut
microbiota
converg
toward
western
human
microbiom
clayton
et
al
age
result
sever
structur
function
chang
immun
system
clinic
associ
increas
frequenc
sever
infecti
diseas
incid
cancer
chronic
inflammatori
disord
autoimmun
gener
dysregul
immun
system
function
refer
immun
senesc
weiskopf
et
al
involut
thymu
diminish
output
cell
perhap
recogn
chang
immun
system
age
howev
effect
age
immun
system
widespread
extend
hematopoiet
stem
cell
lymphoid
progenitor
matur
lymphocyt
secondari
lymphoid
organ
section
chapter
summar
current
understand
agerel
chang
innat
adapt
immun
rhesu
macaqu
emphas
parallel
human
immun
system
also
review
util
nhp
model
develop
test
immunorestor
approach
mani
respons
innat
immun
system
diminish
age
substanti
evid
ageassoci
hyperreact
innat
immun
well
weiskopf
et
al
shaw
et
al
specif
studi
suggest
age
associ
increas
permeabl
mucos
barrier
decreas
phagocyt
chemotact
activ
phagocyt
cell
reduc
nk
cell
cytotox
alter
product
solubl
mediat
weiskopf
et
al
alter
could
lead
increas
pathogen
invas
poor
activ
adapt
immun
respons
mediat
blymphocyt
absolut
number
nk
cell
increas
age
reflect
increas
cell
shaw
et
al
nk
cell
cytotox
abil
produc
cytokin
chemokin
rant
upon
activ
reduc
shaw
et
al
similarli
investig
wisconsin
nation
primat
research
center
demonstr
decreas
nk
cell
cytolyt
activ
correl
strongli
shorten
lifespan
rhesu
macaqu
therebi
serv
use
biomark
longev
coe
ershler
age
result
defect
product
pdc
jing
et
al
furthermor
ageassoci
defect
lpsinduc
product
mdc
report
jing
et
al
gener
ageassoci
declin
product
subunit
share
follow
tlr
stimul
strongli
associ
reduc
influenza
vaccin
antibodi
respons
panda
et
al
contrast
recent
studi
shown
increas
product
monocytederiv
dc
respons
lp
selfdna
old
compar
young
subject
agraw
et
al
compar
rhesu
macaqu
except
increas
monocyt
respons
lp
product
dc
respons
stimul
agonist
declin
age
fig
asquith
et
al
addit
global
analysi
pbmc
pattern
recognit
receptor
prr
express
reveal
significantli
reduc
express
absent
melanoma
retino
acidinduc
gene
rigi
age
compar
adult
macaqu
asquith
et
al
rigi
report
mediat
antivir
respons
number
clinic
signific
pathogen
influenza
type
west
nile
viru
kato
et
al
caus
increas
morbid
mortal
elderli
gubler
la
gruta
et
al
thought
respond
dsdna
bacteria
virus
rathinam
et
al
therefor
interest
see
whether
diminish
rigi
express
human
may
contribut
enhanc
suscept
pathogen
elderli
human
age
immun
system
also
associ
increas
system
inflammatori
cytokin
especi
de
martini
et
al
phenomenon
often
refer
inflammag
hypothes
contribut
develop
andor
aggrav
sever
chronic
diseas
alzheim
osteoporosi
de
martini
et
al
level
increas
older
macaqu
consist
concept
inflammag
asquith
et
al
contrast
level
decreas
age
asquith
et
al
given
modul
effector
cell
activ
surh
sprent
play
import
role
maintain
central
effector
memori
cell
surh
sprent
interest
subset
accumul
age
despit
declin
level
addit
studi
show
mitogen
stimul
whole
blood
purifi
peripher
blood
mononuclear
cell
pbmc
rhesu
macaqu
display
agerel
increas
decreas
product
chang
product
determin
cytokin
elisa
mascarucci
et
al
dendrit
one
strike
featur
immun
senesc
loss
naiv
cell
believ
larg
due
diminish
thymic
output
increas
homeostat
prolifer
lifelong
exposur
pathogen
culmin
convers
larg
proport
naiv
cell
memori
cell
czesnikiewiczguzik
et
al
shift
toward
memori
cell
result
reduc
divers
cell
repertoir
exacerb
appear
cell
clonal
expans
tce
reduc
cell
ratio
pawelec
et
al
senesc
cell
contain
high
level
similarli
rhesu
macaqu
experi
progress
loss
naiv
cell
concomit
increas
memori
cell
especi
effector
memori
em
cell
well
accumul
tce
correl
narrow
cell
repertoir
fig
haberthur
et
al
addit
frequenc
naiv
cell
invers
correl
frequenc
cell
clonal
expans
age
monkey
cicinsain
et
al
shown
human
thymic
involut
decreas
lymphopoeisi
bone
marrow
increas
naiv
cell
turnov
age
rhesu
macaqu
significantli
contribut
deplet
naiv
cell
reserv
cicinsain
et
al
accumul
memori
cell
accompani
increas
frequenc
cell
primarili
among
termin
differenti
memori
cell
jankov
et
al
koch
et
al
moreov
increas
frequenc
cell
link
poor
immun
respons
influenza
vaccin
increas
inflamm
trzonkowski
et
al
addit
cmv
po
individu
show
increas
product
age
wherea
cmv
neg
young
middleag
individu
show
increas
product
age
almanzar
et
al
interestingli
young
age
macaqu
exhibit
similar
frequenc
rhesu
cmvspecif
cell
ident
capabl
produc
equival
respons
rhcmv
reinfect
cicinsain
et
al
data
impli
lack
agerel
declin
rhcmv
immun
age
age
associ
declin
b
cell
function
impair
antibodi
respons
declin
attribut
agerel
reduct
cell
help
well
signific
intrins
chang
within
b
cell
compart
ademokun
et
al
wide
accept
b
cell
number
declin
age
ademokun
et
al
also
evid
age
result
accumul
memori
b
cell
expens
b
cell
ademokun
et
al
regardless
chang
subset
frequenc
age
accompani
signific
decreas
b
cell
repertoir
divers
correl
strongli
frailti
gibson
et
al
b
cell
homeostasi
nhp
wide
investig
recent
studi
indic
similar
observ
older
human
age
rhesu
macaqu
year
old
fewer
circul
b
cell
peripher
blood
adult
anim
year
old
frequenc
antigen
experienc
memori
marginalzon
like
b
cell
increas
age
fig
haberthur
et
al
agerel
chang
innat
adapt
immun
lead
reduc
immun
respons
infect
vaccin
human
turn
contribut
increas
morbid
mortal
infecti
diseas
weinberg
et
al
agerel
increas
suscept
infect
remark
appar
infecti
diseas
influenza
pneumonia
sever
acut
respiratori
syndrom
sar
west
nile
viru
wnv
patient
succumb
infect
year
age
chen
et
al
simonsen
et
al
fein
campbel
et
al
moreov
older
subject
increas
risk
reactiv
latent
pathogen
varicella
zoster
viru
vzv
caus
herp
zoster
shingl
insinga
et
al
describ
human
age
rhesu
macaqu
gener
reduc
b
cell
respons
sever
pathogen
compar
young
anim
instanc
decreas
cell
respons
age
macaqu
modifi
vaccinia
ankara
correl
sever
cell
loss
cicinsain
et
al
age
macaqu
infect
viru
show
higher
viral
load
higher
express
gene
associ
inflamm
innat
respons
bronchoalveloar
lavag
bal
josset
et
al
moreov
despit
higher
cell
prolifer
bal
antigenspecif
cell
respons
delay
reduc
magnitud
age
cynomolg
macaqu
also
suscept
sarscov
infect
young
adult
experienc
increas
multifoc
pulmonari
consolid
alveolar
damag
proinflammatori
respons
despit
compar
viral
titer
gene
express
studi
reveal
type
interferon
reduc
age
monkey
inde
treatment
age
macaqu
type
interferon
reduc
diseas
sever
smit
et
al
similarli
age
african
green
monkey
show
reduc
frequenc
proinflammatori
cytokin
product
peripher
lymphocyt
primarili
cell
b
cell
lung
leukocyt
sarscov
infect
compar
young
anim
clay
et
al
addit
studi
demonstr
age
nonhuman
primat
infect
primat
homologu
human
vzv
simian
varicella
viru
svv
fail
clear
svv
viremia
despit
compar
igg
antibodi
respons
meyer
et
al
contrast
svvspecif
cell
respons
significantli
delay
compar
gener
young
anim
suggest
describ
vzv
agerel
defect
cell
respons
result
poor
control
varicella
viru
replic
dissemin
svv
also
fail
establish
latenc
ganglia
age
rhesu
macaqu
meyer
et
al
studi
use
age
rhesu
macaqu
also
provid
insight
chikungunya
viru
chikv
caus
increas
morbid
mortal
elderli
pardigon
specif
persist
chikv
infect
link
reduc
b
cell
respons
messaoudi
et
al
therefor
infecti
studi
use
young
age
rhesu
macaqu
provid
uniqu
opportun
identifi
agerel
differ
impact
host
immun
respons
determin
differ
age
anim
abil
control
microbi
replic
contrast
studi
describ
age
rhesu
macaqu
show
clinic
diseas
follow
infect
wnv
despit
reduc
cell
prolifer
wertheim
et
al
studi
remind
nhp
model
may
appropri
evalu
mechan
underli
agerel
defect
host
respons
human
pathogen
addit
poor
respons
vaccin
older
individu
gener
lower
respons
vaccin
exampl
follow
influenza
vaccin
person
year
age
gener
antibodi
compar
healthi
adult
year
old
goodwin
et
al
moreov
efficaci
shingl
vaccin
neg
correl
age
oxman
et
al
similarli
sever
studi
report
diminish
immun
respons
vaccin
age
macaqu
instanc
lymphocyt
prolifer
antibodi
product
tetanu
toxoid
vaccin
reduc
older
monkey
especi
male
haberthur
et
al
anoth
studi
show
compromis
mucos
immun
respons
follow
cholera
toxin
vaccin
taylor
daniel
influenza
vaccin
old
rhesu
monkey
result
significantli
lower
antibodi
respons
young
monkey
howev
booster
vaccin
result
antibodi
titer
compar
level
young
monkey
coe
et
al
therefor
age
rhesu
macaqu
provid
great
platform
test
immunogen
efficaci
novel
vaccin
strategi
instanc
age
anim
vaccin
adjuv
cation
lipiddna
complex
show
enhanc
immunogen
significantli
lower
viral
titer
post
challeng
rel
control
carrol
et
al
addit
influenza
viru
antibodi
titer
vaccin
age
macaqu
similar
antibodi
titer
juvenil
macaqu
receiv
inactiv
influenza
vaccin
fluzon
without
adjuv
carrol
et
al
contrast
find
one
studi
found
age
year
old
baboon
gener
robust
antibodi
respons
yersinia
antigen
young
baboon
staci
et
al
one
possibl
explan
differ
outcom
studi
use
anim
potenti
immatur
immun
system
young
control
previou
studi
use
adult
anim
macaqu
past
year
sever
strategi
improv
immun
respons
vaccin
elderli
explor
includ
develop
new
adjuv
differ
vaccin
schedul
new
antigen
parallel
studi
investig
immun
senesc
test
intervent
aim
delayingrevers
agerel
chang
immun
function
nhp
model
especi
rhesu
macaqu
increas
nikolichzugich
sever
studi
demonstr
calor
restrict
cr
delay
age
process
sever
shortliv
speci
rodent
worm
yeast
rodent
cr
preserv
frequenc
cell
maintain
cell
prolif
capac
enhanc
apoptosi
senesc
cell
improv
cell
respons
influenza
nikolichzugich
messaoudi
cr
also
reduc
level
circul
incid
cancer
nikolichzugich
messaoudi
sever
epidemiolog
studi
strongli
suggest
cr
could
similar
benefit
human
robert
schoeller
willcox
et
al
address
question
studi
macaqu
initi
nation
institut
age
mattison
et
al
well
wisconsin
nation
primat
research
center
colman
et
al
report
studi
show
cr
exert
mani
benefici
physiolog
effect
observ
rodent
cefalu
et
al
lane
et
al
initi
cr
earli
adulthood
adultonset
cr
aocr
year
result
higher
frequenc
naiv
cell
divers
cell
repertoir
increas
cell
prolif
capac
reduc
frequenc
memori
cell
secret
proinflammatori
factor
respons
stimul
male
femal
rhesu
macaqu
messaoudi
et
al
aocr
also
shown
reduc
steadyst
plasma
level
rhesu
macaqu
kim
et
al
well
product
pbmc
follow
lp
stimul
induct
oxid
damag
kim
et
al
contrast
result
earlier
studi
found
cr
impact
secret
pbmc
follow
lp
stimul
male
rhesu
macaqu
mascarucci
et
al
discrep
two
data
set
could
due
differ
age
anim
cr
onset
durat
cr
contrast
aocr
juvenileonset
cr
jocr
male
rhesu
macaqu
result
signific
increas
frequenc
termin
differenti
memori
cell
reduct
cell
repertoir
divers
furthermor
jocr
increas
frequenc
cell
secret
respons
stimul
reduc
cell
prolif
capac
similarli
lateonset
year
age
cr
result
reduc
cell
prolif
respons
stimul
messaoudi
et
al
taken
togeth
data
strongli
suggest
optim
window
initi
cr
specif
appear
adultonset
cr
could
improv
immun
wherea
juvenil
age
onset
dietari
restrict
would
expect
result
diminish
immun
respons
infect
vaccin
studi
conduct
rodent
identifi
key
player
cell
homeostasi
surh
sprent
sinc
loss
naiv
cell
accumul
memori
cell
strike
featur
immun
senesc
effort
aim
delay
andor
revers
loss
naiv
cell
reduc
accumul
effector
memori
cell
manipul
network
administr
recombin
rhesu
young
rhesu
macaqu
lead
prolifer
naiv
central
memori
cell
picker
et
al
moreov
treatment
sivinfect
young
rhesu
macaqu
increas
absolut
number
naiv
cell
well
cell
activ
prolifer
like
due
increas
thymic
function
nugeyr
et
al
find
suggest
may
key
player
rejuven
age
immun
system
inde
administr
recombin
age
rhesu
macaqu
increas
thymic
output
aspinal
et
al
howev
treatment
produc
chang
frequenc
naiv
cell
aspinal
et
al
indic
rapid
convers
recent
thymic
emigr
central
memori
cell
indic
transient
increas
number
circul
cell
aspinal
et
al
furthermor
age
femal
rhesu
macaqu
gener
higher
antibodi
respons
follow
vaccin
influenza
compar
nontreat
anim
aspinal
et
al
howev
antibodi
titer
eventu
decreas
set
point
observ
control
anim
preliminari
find
suggest
promis
role
treatment
optim
schedul
administr
dosag
remain
determin
state
earlier
age
accompani
increas
frequenc
em
cell
especi
em
cell
addit
contribut
agerel
increas
inflammatori
cytokin
product
frequenc
em
cell
correl
decreas
respons
vaccin
almanzar
et
al
thu
reduc
frequenc
circul
em
cell
could
potenti
allevi
chronic
degen
diseas
associ
inflamm
improv
respons
vaccin
import
homeostasi
mainten
em
popul
surh
sprent
fact
follow
treatment
neutral
antibodi
rheumatoid
arthriti
synovi
membran
cell
cultur
ra
patient
exhibit
reduct
releas
reduct
product
reduct
releas
andersson
et
al
antibodi
treatment
investig
context
immun
senesc
like
promis
area
intervent
explor
nhp
model
sex
hormon
shown
modul
immun
function
specif
women
suscept
autoimmun
diseas
whitacr
et
al
gener
stronger
antibodi
respons
infect
vaccin
giefingkrol
et
al
less
suscept
bacteri
infect
sepsi
follow
trauma
surgeri
men
wichmann
et
al
observ
suggest
loss
ovarian
steroid
menopaus
could
contribut
immun
senesc
inde
surgic
menopaus
result
decreas
ratio
increas
percentag
nk
cell
decreas
circul
b
cell
kumru
et
al
hand
postmenopaus
women
receiv
hormon
therapi
ht
exhibit
decreas
plasma
level
inflammatori
factor
vural
et
al
lower
product
inflammatori
cytokin
cell
stimul
engelmann
et
al
ht
increas
absolut
number
cell
b
cell
nk
cell
addit
increas
cell
prolif
capac
kumru
et
al
porter
et
al
sinc
femal
nhp
menstrual
cycl
undergo
menopaus
offer
robust
model
determin
abil
ht
revers
immun
senesc
surgic
menopaus
result
alter
cell
homeostasi
diminish
immun
respons
vaccin
adult
age
femal
rhesu
macaqu
engelmann
et
al
ht
partial
rescu
decreas
respons
vaccin
age
femal
rhesu
macaqu
engelmann
et
al
address
caveat
associ
surgic
menopaus
novel
nhp
model
reduc
ovarian
reserv
develop
biodegrad
fiber
contain
diepoxid
vcd
place
next
ovari
appt
et
al
vcd
model
undoubtedli
provid
uniqu
opportun
refin
time
type
durat
ht
regimen
men
increas
age
associ
highli
attenu
level
bioactiv
androgen
especi
testosteron
dehydroepiandrosteron
dhea
harman
et
al
phenomenon
term
andropaus
believ
contribut
perturb
sleepwak
cycl
sarcopenia
osteoporosi
cardiovascular
diseas
diabet
travison
et
al
effect
androgen
immun
system
remain
controversi
previou
studi
show
androgen
ablat
mice
patient
prostat
cancer
result
increas
b
cell
output
elli
et
al
sutherland
et
al
addit
pharmacolog
castrat
result
reduc
frequenc
regulatori
cell
treg
young
men
page
et
al
observ
suggest
androgen
may
suppress
lymphopoiesi
increas
regulatori
cell
frequenc
howev
androgen
supplement
hypogonad
men
reduc
plasma
level
increas
regulatori
cytokin
malkin
et
al
moreov
pharmacolog
castrat
reduc
product
cell
page
et
al
suggest
hypogonad
lead
increas
inflamm
reduc
cell
cytokin
respons
hallmark
immun
senesc
addit
sever
studi
demonstr
testosteron
supplement
older
men
exert
sever
benefit
rang
improv
spatial
cognit
cherrier
et
al
cognit
function
cherrier
et
al
increas
muscl
mass
page
et
al
bone
densiti
villar
et
al
decreas
sever
cardiovascular
diseas
webb
et
al
b
sinc
male
rhesu
macaqu
also
experi
agerel
declin
circul
testosteron
dhea
level
well
mark
attenu
circadian
plasma
profil
urbanski
sorwel
provid
robust
pragmat
anim
model
investig
interplay
androgen
supplement
immun
senesc
anoth
intervent
aim
rejuven
thymu
administr
human
keratinocyt
growth
factor
kgf
stimul
product
differenti
epitheli
cell
varieti
tissu
includ
thymu
alpdogan
et
al
earli
studi
rodent
establish
kgf
treatment
prior
allogen
bone
marrow
transplant
protect
thymic
epitheli
cell
irradi
lead
enhanc
thymopoeisi
acceler
reconstitut
peripher
cell
compart
young
old
mice
min
et
al
moreov
kgf
supplement
improv
celldepend
antibodi
respons
age
mice
min
et
al
data
prompt
studi
involv
nhp
evalu
abil
kgf
promot
thymic
regener
follow
irradi
stem
cell
transplant
result
show
kgftreat
macaqu
wellpreserv
thymic
structur
output
translat
broader
cell
repertoir
improv
antibodi
respons
compar
control
anim
seggewiss
et
al
kgftreat
rhesu
macaqu
demonstr
increas
naiv
cell
frequenc
improv
pronounc
anim
given
multipl
kgf
dose
seggewiss
et
al
interestingli
anim
receiv
multipl
dose
kgf
also
lowest
level
cell
homeostat
prolifer
turn
result
decreas
convers
naiv
memori
cell
thymosin
alpha
one
sever
polypeptid
hormon
secret
thymu
control
matur
cell
investig
possibl
solut
decreas
immun
function
observ
elderli
earli
nhp
studi
femal
rhesu
macaqu
year
old
vaccin
tetanu
toxoid
treat
placebo
ershler
et
al
although
increas
lymphocyt
prolifer
nk
cell
cytotox
activ
observ
anim
signific
effect
antibodi
respons
tetanu
vaccin
observ
ershler
et
al
howev
encourag
increas
lymphocyt
prolifer
test
adjuv
influenza
vaccin
individu
age
year
older
ershler
et
al
among
patient
receiv
follow
influenza
vaccin
fourfold
increas
influenza
antibodi
titer
compar
placebo
group
second
trial
group
involv
elderli
volunt
modest
reduct
number
influenza
case
presenc
observ
develop
influenza
display
mild
nonexist
symptom
compar
placebo
group
ershler
et
al
impli
treatment
might
attenu
diseas
sever
find
highlight
potenti
benefit
suggest
need
revisit
possibl
use
adjuv
vaccin
accord
data
us
censu
bureau
number
older
individu
age
increas
significantli
countri
project
acceler
come
decad
great
stride
accomplish
increas
life
expect
effort
must
direct
improv
health
span
et
al
one
caus
morbid
mortal
among
elderli
popul
increas
suscept
infecti
diseas
due
dysregul
immun
often
refer
immunosenesc
nhp
especi
rhesu
macaqu
play
invalu
role
understand
mechan
immun
senesc
addit
test
intervent
novel
vaccin
strategi
elderli
sever
gap
understand
immun
senesc
rhesu
macaqu
still
exist
exampl
data
ageassoci
chang
innat
immun
b
cell
compart
microbiom
rhesu
macaqu
limit
futur
direct
includ
develop
improv
vaccin
strategi
better
suit
elderli
identif
biomark
age
rejuven
method
revers
immun
senesc
moreov
nhp
robust
model
studi
agerel
increas
suscept
infect
util
test
efficaci
intervent
aim
allevi
nonaidsrel
comorbid
grow
hiv
posit
older
popul
summari
better
understand
immun
dysregul
age
rhesu
macaqu
model
establish
foundat
prevent
treat
agerel
disord
therebi
improv
health
span
